Association between sociodemographic factors and metabolic syndrome in Mexican older adults
DOI:
https://doi.org/10.21149/15321Palabras clave:
metabolic syndrome, National Health and Nutrition Survey, older adults, sociodemographic factors, MexicoResumen
Objective. To estimate the prevalence of metabolic syndrome (MetS) and its association with sociodemographic factors in Mexican older adults (OA). Materials and methods. This study analyzes data from the Mexican National Health and Nutrition Survey 2016. We incorporated data from 804 participants aged 60 years or older. Information on sex, age, body mass index, scholar level, ethnicity, smoking status, geographic region, socioeconomic status, and alcohol consumption was analyzed. For MetS, the International Diabetes Federation harmonized definition was used. Multiple logistic regression models were used to assess the odds ratio (OR) and 95% confidence interval (95%CI) between sociodemographic factors and MetS. Results. The prevalence of MetS was 77.4% (95%CI 72.2,81.9), 71.2% for men, (95%CI 63.2,78.9) and 83.7% for women (95%CI 77.9,88.2). The OA presented higher odds of MetS when they lived with overweight, obesity, and those who had more years of education. Conclusion. The prevalence of MetS among Mexican OA is substantial. Moreover, individuals living with obesity exhibit a heightened odd of experiencing elevated Fasting Plasma Glucose and high blood pressure. This study provides a comprehensive perspective underscoring the imperative for policies aimed at mitigating obesity and addressing other chronic conditions within this population.
Descargas
Citas
Ju SY, Lee JY, Kim DH. Association of metabolic syndrome and its components with all-cause and cardiovascular mortality in the elderly: A metaanalysis of prospective cohort studies. Medicine (Baltimore). 2017;96(45): e8491. https://doi.org/10.1097/MD.0000000000008491
Scuteri A, Najjar SS, Morrell CH, Lakatta EG. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: The Cardiovascular Health Study. Diabetes Care. 2005;28(4):882-7. https://doi.org/10.2337/diacare.28.4.882
Dominguez LJ, Barbagallo M. The biology of the metabolic syndrome and aging. Curr Opin Clin Nutr Metab Care. 2016;19(1):5-11. https://doi.org/10.1097/MCO.0000000000000243
Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459-544. https://doi.org/10.1016/S0140-6736(16)31012-1
Parra-Rodríguez L, González-Meljem JM, Gómez-Dantés H, Gutiérrez-Robledo LM, López-Ortega M, García-Peña C, et al. The Burden of Disease in Mexican Older Adults: premature mortality challenging a limitedresource health system. J Aging Health. 2020;32(7-8):543-53. https://doi.org/10.1177/0898264319836514
Ortiz-Rodríguez MA, Yáñez-Velasco L, Carnevale A, Romero-Hidalgo S, Bernal D, Aguilar-Salinas C, et al. Prevalence of metabolic syndrome among elderly Mexicans. Arch Gerontol Geriatr. 2017;73:288-93. https://doi.org/10.1016/j.archger.2017.09.001
Salas R, Bibiloni M del M, Ramos E, Villareal JZ, Pons A, Tur J, et al. Metabolic syndrome prevalence among Northern Mexican adult population. PLoS ONE. 2014;9(8):e105581. https://doi.org/10.1371/journal.pone.0105581
Alberti KGMM, Zimmet P. The metabolic syndrome: Time to reflect. Curr Diab Rep. 2006;6(4):259-61. https://doi.org/10.1007/s11892-006-0057-0
Merchant RA, Chan YH, Lim JY, Morley JE. Prevalence of metabolic syndrome and association with grip strength in older adults: findings from the HOPE Study. Diabetes Metab Syndr Obes Targets Ther. 2020;13:2677-86. https://doi.org/10.2147/DMSO.S260544
Nishikawa H, Asai A, Fukunishi S, Nishiguchi S, Higuchi K. Metabolic syndrome and sarcopenia. Nutrients. 2021;13(10):3519. https://doi.org/10.3390/nu13103519
Su YH, Chang YM, Kung CY, Sung CK, Foo WS, Wu MH, et al. A study of correlations between metabolic syndrome factors and osteosarcopenic adiposity. BMC Endocr Disord. 2021;21(1). https://doi.org/10.1186/s12902-021-00880-w
Liaw FY, Kao TW, Wu LW, Wang CC, Yang HF, Peng TC, et al. Components of metabolic syndrome and the risk of disability among the elderly population. Sci Rep. 2016;6(1). https://doi.org/10.1038/srep22750
Tsai CK, Kao TW, Lee JT, Wu CJ, Hueng DY, Liang CS, et al. Increased risk of cognitive impairment in patients with components of metabolic syndrome. Medicine (Baltimore). 2016;95(36):e4791. https://doi.org/10.1097/MD.0000000000004791
Terschüren C, Damerau L, Petersen EL, Harth V, Agustin M, Zyriax BC. Association of dietary pattern, lifestyle and chronotype with metabolic syndrome in elderly-lessons from the population-based Hamburg City health study. Int J Environ Res Public Health. 2022;19(1):377. https://doi.org/10.3390/ijerph19010377
Papaioannou KG, Kadi F, Nilsson A. Benefits of fruit and vegetable consumption on prevalence of metabolic syndrome are independent of physical activity behaviors in older adults. Nutrients. 2022;14(2):263. https://doi.org/10.3390/nu14020263
Li Y, Zhao L, Yu D, Wang Z, Ding G. Metabolic syndrome prevalence and its risk factors among adults in China: A nationally representative crosssectional study. PLoS ONE. 2018;13(6):e0199293. https://doi.org/10.1371/journal.pone.0199293
Barranco-Ruiz Y, Villa-González E, Venegas-Sanabria LC, Chavarro-Carvajal DA, Cano-Gutiérrez CA, Izquierdo M, et al. Metabolic syndrome and its associated factors in older adults: a secondary analysis of SABE Colombia in 2015. Metab Syndr Relat Disord. 2020;18(8):389-98. https://doi.org/10.1089/met.2019.0066
De Oliveira-Costa AC, De Oliveira-Duarte YA, Bof de Andrade F. Síndrome metabólica: inatividade física e desigualdades socioeconômicas entre idosos brasileiros não institucionalizados. Rev Bras Epidemiol. 2020;23. https://doi.org/10.1590/1980-549720200046
Romero-Martínez M, Shamah-Levy T, Cuevas-Nasu L, Gómez-Humarán IM, Gaona-Pineda EB, Gómez-Acosta LM, et al. Diseño metodológico de la Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. Salud Publica Mex. 2017;59(3):299. https://doi.org/10.21149/8593
Hernández-Alcaraz C, Shamah-Levy T, Romero-Martínez M, Sepúlveda-Amor J, Aguilar-Salinas CA, Rivera-Dommarco JA, et al. Submuestra para el análisis de enfermedades crónicas con biomarcadores, Encuesta Nacional de Salud y Nutrición 2016. Salud Publica Mex. 2020;62(5):504-10. https://doi.org/10.21149/11306
Howe LD, Galobardes B, Matijasevich A, Gordon D, Johnston D, Onwujekwe O, et al. Measuring socio-economic position for epidemiological studies in low- and middle-income countries: a methods of measurement in epidemiology paper. Int J Epidemiol. 2012;41(3):871-86. https://doi.org/10.1093/ije/dys037
Campos-Nonato I, Hernández-Barrera L, Pedroza-Tobías A, Medina C, Barquera S. Hipertensión arterial en adultos mexicanos: prevalencia, diagnóstico y tipo de tratamiento. Ensanut MC 2016. Salud Publica Mex. 2018;60(3):233-43. https://doi.org/10.21149/8813
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502. https://doi.org/10.1093/clinchem/18.6.499
Hernández-Alcaraz C, Aguilar-Salinas CA, Mendoza-Herrera K, Pedroza-Tobías A, Villalpando S, Shamah-Levy T, et al. Dyslipidemia prevalence, awareness, treatment and control in Mexico: results of the Ensanut 2012. Salud Publica Mex. 2020;62(2):137-46. https://doi.org/10.21149/10520
Basto-Abreu A, Barrientos-Gutiérrez T, Rojas-Martínez R, Aguilar-Salinas CA, López-Olmedo N, De la Cruz-Góngora V, et al. Prevalencia de diabetes y descontrol glucémico en México: resultados de la Ensanut 2016. Salud Publica Mex. 2019;62(1):50-9. https://doi.org/10.21149/10752
Kıskaç M, Soysal P, Smith L, Capar E, Zorlu M. What is the optimal body mass index range for older adults? Ann Geriatr Med Res. 2022;26(1):49-57. https://doi.org/10.4235/agmr.22.0012
Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-45. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
Alemán-Mateo H, López-Teros MT, Urquidez-Romero R, Huesca L. Prevalence of metabolic syndrome and its determinants in older Mexican non-diabetic adults. Nutr Hosp. 2018;35(2):294-304. https://doi.org/10.20960/nh.1518
Pucci G, Alcidi R, Tap L, Battista F, Mattace-Raso F, Schillaci G. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature. Pharmacol Res. 2017;120:34-42. https://doi.org/10.1016/j.phrs.2017.03.008
Gallardo-Alfaro L, Bibiloni M del M, Mascaró CM, Montemayor S, Ruiz-Canela M, Salas-Salvador J, et al. Leisure-time physical activity, sedentary behaviour and diet quality are associated with metabolic syndrome severity: The PREDIMED-Plus Study. Nutrients. 2020;12(4):1013. https://doi.org/10.3390/nu12041013
Bechtold M, Palmer J, Valtos J, Lasiello C, Sowers J. Metabolic syndrome in the elderly. Curr Diab Rep. 2006;6(1):64-71. https://doi.org/10.1007/s11892-006-0054-3
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2024 Salud Pública de México
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Al proponer un trabajo para su publicación, los autores aceptan las condiciones contenidas en las presentes normas y ceden a Salud Pública de México los derechos patrimoniales sobre el artículo en cuestión, a fin de que ésta lo edite, publique, reproduzca, difunda, comercialice, traduzca o autorice su traducción a cualquier idioma.
Los derechos transferidos incluyen la publicación del artículo por cualquier medio, sea éste impreso, magnético o electrónico, o por cualquier otro soporte o medio de difusión que exista o pueda crearse en el futuro, así como la realización de publicaciones mediante la concesión de licencias totales o parciales a terceros.
Los artículos aceptados serán publicados en Salud Pública de México bajo una licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional.
Los trabajos propuestos deberán ser originales e inéditos, y no podrán presentarse a ninguna otra revista mientras se encuentren sometidos a la consideración de Salud Pública de México.También se reciben trabajos completos publicados previamente en forma de resumen, o trabajos no publicados presentados en congresos o seminarios.
Todos los trabajos serán publicados con pleno conocimiento de los autores.
Los artículos firmados son responsabilidad de los autores y no necesariamente reflejan la opinión de la revista, del Instituto Nacional de Salud Pública o de la institución a la que están afiliados los autores.
